The effect of soy isoflavones in migraine
Phase 3
Recruiting
- Conditions
- migraine.Migraine
- Registration Number
- IRCT20121216011763N44
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 88
Inclusion Criteria
Women from the age of 18 to menopause
Diagnosis of migraine by a neurologist
Willing to work with the project
Exclusion Criteria
With breast cancer and endometrial cancer
Problem or risk of breast or endometrial cancer in a breast examination by a gynecologist
Having a family history of endometrial and breast cancer
OCP medication use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Migraine symptoms (severity, frequency, duration of migraine). Timepoint: At baseline and after eight weeks. Method of measurement: Questionnaire.;Serum levels of calcitonin-associated peptide (CGRP). Timepoint: At baseline and after eight weeks. Method of measurement: Laboratory analysis (blood test).
- Secondary Outcome Measures
Name Time Method Depression, stress, anxiety. Timepoint: At baseline and after eight weeks. Method of measurement: DASS-21questionnaire.;Quality of Life in Migraine Patients. Timepoint: Quality of Life in Migraine Patients. Method of measurement: Migraine –Specific Quality of Life(MSQ)questionnaire.